AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35527114 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.01% atropine combined with orthokeratology (OK)
Number of subjects: 62
Study 35527114 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo solution combined with orthokeratology (OK)
Number of subjects: 62
Study 35527114 — intervention group
Group type: COMPARATOR
Intervention: 0.01% atropine with spectacles
Number of subjects: 62
Study 35527114 — intervention group
Group type: COMPARATOR
Intervention: Placebo solution with spectacles
Number of subjects: 62
Study 32940765 — intervention group
Group type: COMPARATOR
Intervention: Clotrimazole (CT) 100 mg
Number of subjects: 150
Study 32940765 — intervention group
Group type: EXPERIMENTAL
Intervention: Dequalinium chloride (DQC) 10 mg
Number of subjects: 150
Study 36217643 — intervention group
Group type: EXPERIMENTAL
Intervention: SmearOFF as the final irrigant + 2% Chlorhexidine gel as intracanal medicament (n=14)
Number of subjects: 28
Study 36217643 — intervention group
Group type: COMPARATOR
Intervention: 5.25% Sodium Hypochlorite (NaOCl) + Calcium Hydroxide (Ca(OH)2) as intracanal medicament (n=14)
Number of subjects: 28
Study 34463425 — intervention group
Group type: EXPERIMENTAL
Intervention: liraglutide 1.8 mg
Number of subjects: 2233
Study 34463425 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 2233
Study 34463425 — intervention group
Group type: EXPERIMENTAL
Intervention: liraglutide
Number of subjects: 2233
Study 34187137 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Centered Empowerment Model (FCEM); 8 sessions over 2 months
Number of subjects: 60
Study 34187137 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study 35652260 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole (LZ) 5 mg
Number of subjects: 31
Study 35652260 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 33271884 — intervention group
Group type: EXPERIMENTAL
Intervention: e-health intervention (computer-based prompts)
Number of subjects: 14
Study 33271884 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 14
Study 35782695 — intervention group
Group type: EXPERIMENTAL
Intervention: Tensioning NM
Number of subjects: 90
Study 35782695 — intervention group
Group type: EXPERIMENTAL
Intervention: Sliding NM
Number of subjects: 90
Study 35782695 — intervention group
Group type: COMPARATOR
Intervention: Sham NM
Number of subjects: 90
Study 35511686 — intervention group
Group type: EXPERIMENTAL
Intervention: Video instruction
Number of subjects: 54
Study 35511686 — intervention group
Group type: EXPERIMENTAL
Intervention: Instruction via images
Number of subjects: 54
Study 35511686 — intervention group
Group type: COMPARATOR
Intervention: Written panel instructions
Number of subjects: 54
Study 32991363 — intervention group
Group type: COMPARATOR
Intervention: 2D fluoroscopy
Number of subjects: 41
Study 32991363 — intervention group
Group type: COMPARATOR
Intervention: 3D navigation
Number of subjects: 41
Study 35917264 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-pulsed 1,064-nm Nd:YAG laser
Number of subjects: 20
Study 35917264 — intervention group
Group type: EXPERIMENTAL
Intervention: Trichloroacetic acid (TCA) 20%
Number of subjects: 20
Study 35917264 — intervention group
Group type: COMPARATOR
Intervention: Both modalities (Nd:YAG laser and TCA 20%)
Number of subjects: 20
Study 34976331 — intervention group
Group type: EXPERIMENTAL
Intervention: Active initiation of secondary prevention therapy (aspirin, beta-blockers, statins, ACEI/ARBs)
Number of subjects: 1083
Study 34976331 — intervention group
Group type: COMPARATOR
Intervention: Passive continuation of prior medication (aspirin, beta-blockers, statins)
Number of subjects: 1083
Study 32652910 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone maintenance therapy (MMT)
Number of subjects: 80
Study 32652910 — intervention group
Group type: COMPARATOR
Intervention: Non-drug users (N-MMT group)
Number of subjects: 80
Study 36053844 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronate
Number of subjects: 2000
Study 36053844 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2000
Study 33581958 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D modified digital surgical guide plates and preformed titanium plates (Group A)
Number of subjects: 22
Study 33581958 — intervention group
Group type: COMPARATOR
Intervention: Preformed titanium plates only (Group B)
Number of subjects: 22
Study 33581958 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (Group C)
Number of subjects: 22
Study 35093230 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactivated whole‐virion SARS‐CoV‐2 vaccine (CoronaVac)
Number of subjects: 0
Study 35093230 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33619579 — intervention group
Group type: EXPERIMENTAL
Intervention: LITE programme
Number of subjects: 61
Study 33619579 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 61
Study 32301590 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraarticular Trans-capsaicin
Number of subjects: 0
Study 32301590 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 36431193 — intervention group
Group type: EXPERIMENTAL
Intervention: Diacutaneous fibrolysis (DF) added to pharmacological intervention, 3 sessions
Number of subjects: 82
Study 36431193 — intervention group
Group type: COMPARATOR
Intervention: Pharmacological intervention alone (standard care group)
Number of subjects: 82
Study 35180137 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician recommended school accommodations (≤90 days post-injury)
Number of subjects: 200
Study 35180137 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician recommended school accommodations
Number of subjects: 200
Study 34733813 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga group (N = 49) attended a yoga course consisting of 10 sessions (1.5 h each) on a weekly basis
Number of subjects: 82
Study 34733813 — intervention group
Group type: COMPARATOR
Intervention: Control group (N = 33) did not receive any intervention
Number of subjects: 82
Study 36003059 — intervention group
Group type: EXPERIMENTAL
Intervention: German condition (second language)
Number of subjects: 32
Study 36003059 — intervention group
Group type: COMPARATOR
Intervention: Spanish condition (first language)
Number of subjects: 32
Study 33386289 — intervention group
Group type: EXPERIMENTAL
Intervention: Holmium laser en-bloc resection (HolERBT)
Number of subjects: 100
Study 33386289 — intervention group
Group type: COMPARATOR
Intervention: Conventional transurethral resection of bladder tumor (cTURBT)
Number of subjects: 100
Study 34474033 — intervention group
Group type: EXPERIMENTAL
Intervention: MISA 1 cohort (2007-2009)
Number of subjects: 100
Study 34474033 — intervention group
Group type: EXPERIMENTAL
Intervention: MISA 2 cohort (2019)
Number of subjects: 100
Study 33878619 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic exoskeleton-assisted exercise rehabilitation (REAER)
Number of subjects: 10
Study 33878619 — intervention group
Group type: COMPARATOR
Intervention: Conventional gait training (CGT)
Number of subjects: 10
Study 32129196 — intervention group
Group type: EXPERIMENTAL
Intervention: Step-wise sodium profile and ultrafiltration (UF)
Number of subjects: 32
Study 32129196 — intervention group
Group type: EXPERIMENTAL
Intervention: Linear sodium profile and ultrafiltration (UF)
Number of subjects: 32
Study 32129196 — intervention group
Group type: COMPARATOR
Intervention: Routine method
Number of subjects: 32
Study 35175967 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV16+
Number of subjects: 120
Study 35175967 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV18 or 18/45+
Number of subjects: 120
Study 35175967 — intervention group
Group type: EXPERIMENTAL
Intervention: Other genotypes+
Number of subjects: 120
Study 35175967 — intervention group
Group type: EXPERIMENTAL
Intervention: PD-L1 positive tumors (CPS)
Number of subjects: 120
Study 35175967 — intervention group
Group type: EXPERIMENTAL
Intervention: PD-L1 positive tumors (TPS)
Number of subjects: 120
Study 35175967 — intervention group
Group type: EXPERIMENTAL
Intervention: Tumors with patterns B and C
Number of subjects: 120
Study 33477648 — intervention group
Group type: EXPERIMENTAL
Intervention: Cistanche tubulosa (CT) extract for 12 weeks
Number of subjects: 26
Study 33477648 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 33477648 — intervention group
Group type: EXPERIMENTAL
Intervention: Cistanche tubulosa (CT) extract
Number of subjects: 26
Study 35305137 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid-based cytology (LBC) diagnostics followed by a single operation with panendoscopy and incisional biopsy for confirmation of LBC result, then transoral tumor resection ± neck dissection and tracheostomy
Number of subjects: 25
Study 35305137 — intervention group
Group type: COMPARATOR
Intervention: Diagnostic panendoscopy with incisional biopsy followed by a second operation with transoral tumor resection ± neck dissection and tracheostomy
Number of subjects: 25
Study 35427491 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccination on attendance (VoA)
Number of subjects: 0
Study 35427491 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccination on diagnosis (VoD)
Number of subjects: 0
Study 35427491 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccination according to risk (VaR)
Number of subjects: 0
Study 35427491 — intervention group
Group type: EXPERIMENTAL
Intervention: 4CMenB under VaR
Number of subjects: 0
Study 35427491 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothetical gonorrhoea vaccine
Number of subjects: 0
Study 33615642 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 4744
Study 33615642 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4744
Study 32243716 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg of ketorolac tromethamine prior to local anaesthesia with 2% lignocaine and 1:80,000 adrenaline
Number of subjects: 126
Study 32243716 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg of ketorolac tromethamine prior to local anaesthesia with 4% articaine and 1:100,000 adrenaline
Number of subjects: 126
Study 32243716 — intervention group
Group type: COMPARATOR
Intervention: Control group (no ketorolac)
Number of subjects: 126
Study 34998795 — intervention group
Group type: EXPERIMENTAL
Intervention: Gradient-boosting decision tree (GBDT) model
Number of subjects: 1099
Study 34998795 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional Cox proportional hazard model
Number of subjects: 1099
Study 34998795 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning models (3 models including GBDT)
Number of subjects: 1099
Study 34998795 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic and histologic findings
Number of subjects: 1099
Study 34998795 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized cumulative incidence prediction curve
Number of subjects: 1099
Study 32912759 — intervention group
Group type: EXPERIMENTAL
Intervention: Care bundle implementation (intervention group)
Number of subjects: 110
Study 32912759 — intervention group
Group type: COMPARATOR
Intervention: Non-standardized care (control group)
Number of subjects: 110
Study 34984933 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to local Paralympic Games coverage information via e-mail
Number of subjects: 119
Study 34984933 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving no e-mails about coverage
Number of subjects: 119
Study 32888192 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous intravenous infusion (CII) of enoxaparin
Number of subjects: 38
Study 32888192 — intervention group
Group type: COMPARATOR
Intervention: Standard subcutaneous bolus (SCB) of enoxaparin
Number of subjects: 38
Study 35164586 — intervention group
Group type: EXPERIMENTAL
Intervention: Thematic framing with heterosexual male perpetrators
Number of subjects: 750
Study 35164586 — intervention group
Group type: EXPERIMENTAL
Intervention: Punishment preferences for heterosexual male perpetrators
Number of subjects: 750
Study 35164586 — intervention group
Group type: EXPERIMENTAL
Intervention: Punishment preferences for male or female homosexual perpetrators
Number of subjects: 750
Study 32216731 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic intensity-modulated radiation therapy (IMRT)
Number of subjects: 5289
Study 32273209 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 laser microlaryngeal surgery
Number of subjects: 80
Study 32273209 — intervention group
Group type: COMPARATOR
Intervention: Conventional microlaryngeal surgery
Number of subjects: 80
Study 32273209 — intervention group
Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 80
Study 36490309 — intervention group
Group type: EXPERIMENTAL
Intervention: metformin combined with neoadjuvant chemotherapy and trastuzumab
Number of subjects: 0
Study 36490309 — intervention group
Group type: COMPARATOR
Intervention: neoadjuvant chemotherapy and trastuzumab without metformin
Number of subjects: 0
Study 33845173 — intervention group
Group type: EXPERIMENTAL
Intervention: tACS over prefrontal or somatosensory cortices at alpha or gamma frequencies
Number of subjects: 29
Study 33845173 — intervention group
Group type: COMPARATOR
Intervention: Sham tACS
Number of subjects: 29
Study 33845173 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha tACS over somatosensory cortex
Number of subjects: 29
Study 32729631 — intervention group
Group type: EXPERIMENTAL
Intervention: Pimavanserin (34 mg)
Number of subjects: 76
Study 35273972 — intervention group
Group type: EXPERIMENTAL
Intervention: Alginate drink (one bottle twice a day for 8 weeks after A-FMT)
Number of subjects: 2
Study 35273972 — intervention group
Group type: COMPARATOR
Intervention: Placebo (instead of alginate drink)
Number of subjects: 2
Study 35273972 — intervention group
Group type: EXPERIMENTAL
Intervention: Alginate drink
Number of subjects: 2
Study 33298145 — intervention group
Group type: EXPERIMENTAL
Intervention: Football training (n = 30)
Number of subjects: 60
Study 33298145 — intervention group
Group type: COMPARATOR
Intervention: Aerobic exercise training (n = 30)
Number of subjects: 60
Study 34175217 — intervention group
Group type: EXPERIMENTAL
Intervention: Familias Unidas for Health and Wellness (FUHW)
Number of subjects: 280
Study 32183874 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Occupation-Based programme (COB-MS)
Number of subjects: 120
Study 32183874 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual, wait-list control group
Number of subjects: 120
Study 35985975 — intervention group
Group type: EXPERIMENTAL
Intervention: Loop DJB‐SG
Number of subjects: 96
Study 35985975 — intervention group
Group type: COMPARATOR
Intervention: Roux-en-Y DJB‐SG
Number of subjects: 96
Study 33334157 — intervention group
Group type: COMPARATOR
Intervention: Pathway 1 (usual care): Community health workers (CHWs) and primary care providers (PCPs) refer patients to district-level mental health clinics.
Number of subjects: 4700000
Study 33334157 — intervention group
Group type: EXPERIMENTAL
Intervention: Pathway 2 (screen, refer, and treat): CHWs screen and refer patients to PCPs for behavioral and pharmacological EBIs in community clinics.
Number of subjects: 4700000
Study 33334157 — intervention group
Group type: EXPERIMENTAL
Intervention: Pathway 3 (community mental health stepped care): CHWs screen patients and deliver behavioral EBIs in the community and refer medication management cases to PCPs in clinics.
Number of subjects: 4700000
Study 35585519 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-nutritive sucking on mother’s finger (A)
Number of subjects: 150
Study 35585519 — intervention group
Group type: EXPERIMENTAL
Intervention: Pacifier (B)
Number of subjects: 150
Study 35585519 — intervention group
Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 150
Study 33675081 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey protein (70 g/280 kcal) drink
Number of subjects: 32
Study 33675081 — intervention group
Group type: COMPARATOR
Intervention: Control (water with diet cordial, 2 kcal) drink
Number of subjects: 32
Study 35148800 — intervention group
Group type: EXPERIMENTAL
Intervention: Community intervention for tuberculosis household child contact management
Number of subjects: 0
Study 34959840 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-calorie diet (LCD) for 8 weeks
Number of subjects: 162
Study 34959840 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss maintenance period (12 weeks)
Number of subjects: 162
Study 34959840 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-calorie diet (LCD)
Number of subjects: 162
Study 34959840 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss maintenance period
Number of subjects: 162
Study 34436927 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored intervention
Number of subjects: 349
Study 34436927 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 349
Study 32691102 — intervention group
Group type: EXPERIMENTAL
Intervention: Municipal solid waste compost (MSWC) at 40 t ha−1 year−1
Number of subjects: 4
Study 32691102 — intervention group
Group type: EXPERIMENTAL
Intervention: Municipal solid waste compost (MSWC) at 80 t ha−1 year−1
Number of subjects: 4
Study 32691102 — intervention group
Group type: EXPERIMENTAL
Intervention: Municipal solid waste compost (MSWC) at 120 t ha−1 year−1
Number of subjects: 4
Study 32691102 — intervention group
Group type: EXPERIMENTAL
Intervention: Farmyard manure (FM) at 40 t ha−1 year−1
Number of subjects: 4
Study 32691102 — intervention group
Group type: EXPERIMENTAL
Intervention: Farmyard manure (FM) at 120 t ha−1 year−1
Number of subjects: 4
Study 32691102 — intervention group
Group type: COMPARATOR
Intervention: Control (unamended soil)
Number of subjects: 4
Study 36760537 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial Extracorporeal Shock Wave Therapy (ESWT) applied once a week for 5 weeks, combined with a 5-week advanced rehabilitation training program (30 minutes/session, 5 times/week) starting at 3 months postoperatively
Number of subjects: 30
Study 36760537 — intervention group
Group type: COMPARATOR
Intervention: Control group followed a 5-week advanced rehabilitation training program (30 minutes/session, 5 times/week) starting at 3 months postoperatively
Number of subjects: 30
Study 33196155 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban (20 mg once daily)
Number of subjects: 1005
Study 33196155 — intervention group
Group type: COMPARATOR
Intervention: Warfarin (dose-adjusted, target INR 2.0 to 3.0)
Number of subjects: 1005
Study 33196155 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 1005
Study 33196155 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 1005
Study 35781888 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-day antibiotic protocol (500 mg amoxicillin and metronidazole 3 times a day for 3 days, followed by placebo for 4 days)
Number of subjects: 50
Study 35781888 — intervention group
Group type: COMPARATOR
Intervention: 7-day antibiotic protocol (500 mg amoxicillin and metronidazole 3 times a day for 7 days)
Number of subjects: 50
Study 34112605 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-week meditation and mindfulness programme with standard supportive care
Number of subjects: 76
Study 34112605 — intervention group
Group type: COMPARATOR
Intervention: Standard supportive care only
Number of subjects: 76
Study 35485332 — intervention group
Group type: EXPERIMENTAL
Intervention: JNJ-64794964 0.2 mg
Number of subjects: 34
Study 35485332 — intervention group
Group type: EXPERIMENTAL
Intervention: JNJ-64794964 0.6 mg
Number of subjects: 34
Study 35485332 — intervention group
Group type: EXPERIMENTAL
Intervention: JNJ-64794964 1.25 mg
Number of subjects: 34
Study 35485332 — intervention group
Group type: EXPERIMENTAL
Intervention: JNJ-64794964 1.8 mg
Number of subjects: 34
Study 35485332 — intervention group
Group type: EXPERIMENTAL
Intervention: JNJ-64794964 1.25 mg (MD phase)
Number of subjects: 34
Study 35485332 — intervention group
Group type: COMPARATOR
Intervention: Placebo (SAD phase)
Number of subjects: 34
Study 35485332 — intervention group
Group type: COMPARATOR
Intervention: Placebo (MD phase)
Number of subjects: 34
Study 35485332 — intervention group
Group type: EXPERIMENTAL
Intervention: JNJ-64794964
Number of subjects: 34
Study 35810356 — intervention group
Group type: EXPERIMENTAL
Intervention: rh‐bFGF nasal‐spray
Number of subjects: 75
Study 35810356 — intervention group
Group type: EXPERIMENTAL
Intervention: rh‐bFGF nasal‐drops
Number of subjects: 75
Study 35810356 — intervention group
Group type: EXPERIMENTAL
Intervention: rh‐bFGF nasal‐spray and drop
Number of subjects: 75
Study 35810356 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 75
Study 34371914 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored feedback (graph and prompt showing the proportion of ‘everyday’ foods selected)
Number of subjects: 2200
Study 34371914 — intervention group
Group type: COMPARATOR
Intervention: Standard online ordering system
Number of subjects: 2200
Study 34371914 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Tailored feedback and Standard online ordering)
Number of subjects: 2200
Study 32727540 — intervention group
Group type: EXPERIMENTAL
Intervention: Persian version of the Celiac Disease Adherence Test (Pv‐CDAT)
Number of subjects: 230
Study 36335297 — intervention group
Group type: EXPERIMENTAL
Intervention: 100-μg dexmedetomidine plus 35-mL 0.5% levobupivacaine
Number of subjects: 60
Study 36335297 — intervention group
Group type: EXPERIMENTAL
Intervention: 50-μg dexmedetomidine plus 35-mL 0.5% levobupivacaine
Number of subjects: 60
Study 36335297 — intervention group
Group type: COMPARATOR
Intervention: 35-mL 0.5% levobupivacaine plus normal saline
Number of subjects: 60
Study 33908301 — intervention group
Group type: EXPERIMENTAL
Intervention: Reparixin
Number of subjects: 12
Study 33908301 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 36049407 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 Hz rTMS over right dorsolateral prefrontal cortex for 10 consecutive days
Number of subjects: 25
Study 36049407 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 25
Study 36192785 — intervention group
Group type: COMPARATOR
Intervention: REP (Replicating Effective Programs)
Number of subjects: 32
Study 36192785 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced REP (with 9 months of external facilitation)
Number of subjects: 32
Study 33065664 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramedullary nail
Number of subjects: 12
Study 33065664 — intervention group
Group type: COMPARATOR
Intervention: Locking plate and lag screw fixation
Number of subjects: 12